Keratoacanthomas associated with sorafenib therapy

被引:74
作者
Kong, Heidi H.
Cowen, Edward W.
Azad, Nilofer S.
Dahut, William
Gutierrez, Martin
Turner, Maria L.
机构
[1] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] NCI, Med Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1016/j.jaad.2006.10.032
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:171 / 172
页数:2
相关论文
共 3 条
[1]   BAY 43-9006 inhibition of oncogenic RET mutants [J].
Carlomagno, F ;
Anaganti, S ;
Guida, T ;
Salvatore, G ;
Troncone, G ;
Wilhelm, SM ;
Santoro, M .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (05) :326-334
[2]   Raf kinase inhibitors in oncology [J].
Strumberg, D ;
Seeber, S .
ONKOLOGIE, 2005, 28 (02) :101-107
[3]   KERATOACANTHOMA IN A SUB-TROPICAL CLIMATE [J].
SULLIVAN, JJ ;
COLDITZ, GA .
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 1979, 20 (01) :34-40